Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A great watch. Focuses on NAC ($META) and mentions Alternate Health ($AHG) investment at 18m30s in the video. "Alternate Health will be a major player in the US." AHG and META both have participated in each others Private Placements.
https://aptnnews.ca/2019/01/15/first-nation-has-close-to-50m-invested-in-cannabis-industry/
#AHG #META #CreeNation #CannabisInvesting
A great watch. Focuses on NAC ($META) and mentions Alternate Health ($AHG) investment at 18m30s in the video. "Alternate Health will be a major player in the US." AHG and META both have participated in each others Private Placements.
https://aptnnews.ca/2019/01/15/first-nation-has-close-to-50m-invested-in-cannabis-industry/
#AHG #META #CreeNation #CannabisInvesting
NEWS - ALTERNATE HEALTH SECURES SECOND SET OF LICENSES FOR CANNABIS MANUFACTURING AND DISTRIBUTION IN LOS ANGELES
https://webfiles.thecse.com/2019.01.18_-_Sun_Valley_License.pdf?yjs1lH037enXbRUNKKdN21BNFrtIlrpN&fbclid=IwAR3BJ0tBcYbS-YdGrVIXaSprWRJq6cPP88WV47eS_RfFGiqVv866owpj6tU
NEWS - ALTERNATE HEALTH SECURES SECOND SET OF LICENSES FOR CANNABIS MANUFACTURING AND DISTRIBUTION IN LOS ANGELES
https://webfiles.thecse.com/2019.01.18_-_Sun_Valley_License.pdf?yjs1lH037enXbRUNKKdN21BNFrtIlrpN&fbclid=IwAR3BJ0tBcYbS-YdGrVIXaSprWRJq6cPP88WV47eS_RfFGiqVv866owpj6tU
NAC involved heavily w latest AHG Private placement round.
3 major participants in the last private placement round for $AHG all have direct connections to NAC. Alternative health has also participated in previous NAC PP rounds.
Here is what I have learned.
1) PI Financial Corp. ITF Paskwayak Business Development Corporation Ltd. Opaskwyak, Manitoba Bought 3.75 Million shares in the last Private Placement.
After doing some digging i noticed that Paskwayak Business Development Corporation are First Nations from the Opaskwayak Cree Nation.
- They are heavily invested in National Access Cannabis Corp.
https://ceo.ca/@nasdaq/paskwayak-business-development-corporation-acquires
- They are also invested in Trichome Financial Corp. (Specialty Finance for the Cannabis Industry)
https://www.newswire.ca/news-releases/trichome-financial-corp-announces-closing-of-private-placement-and-provides-corporate-update-692684761.html
2) PI Financial Corp.For: Mark Goliger Burlington, ON bought 125,000 shares. He is CEO of National Access Cannabis.
3) Rocco Meliambro has 750,000 shares. He is on the board of National Access Cannabis Corp
See full list of AHG Private placement participants here: https://webfiles.thecse.com/CSE_Form_9_-_NoticeofIssuanceofSecurities_-_21Dec18_-_final.pdf
Relationship b/w AHG and LHS?
News Release:
Liberty Health Sciences Taps FlorPass As Florida’s First Online Shopping Portal For Its Premium Cannabis Products
(“Liberty” or the “Company”), a provider of trusted, high quality cannabis experiences, announced today that it has received approval by the Florida Department of Health to implement FlorPass as the state’s first online patient management system, connecting patients, physicians and cannabis retailers in one system to provide enhanced care.
FlorPass is developed by Alternate Health Corp
FlorPass is developed by Alternate Health Corp., an international corporation that provides software solutions for the medical cannabis industry. FlorPass is the Florida equivalent of Alternate Health’s CanaPass Cannabis Compliance technology, which is currently operational nationwide in Canada.
- https://www.newcannabisventures.com/liberty-health-sciences-taps-florpass-as-floridas-first-online-shopping-portal-for-its-premium-cannabis-products/
Relationship b/w AHG and MedMen?
News Release:
Alternate Health Signs Agreement with Medmen to Launch Statepass Beta in New York Dispensaries
https://www.prnewswire.com/news-releases/alternate-health-signs-agreement-with-medmen-to-launch-statepass-beta-in-new-york-dispensaries-675529303.html
("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international corporation that provides software solutions for the medical cannabis industry, today announced that the Company has entered into a software-as-a-service agreement with MedMen, one of the largest cannabis companies in the U.S., to provide e-commerce and digital payment services. Alternate Health's StatePass system will begin beta testing with MedMen in their New York dispensaries.
"We are very pleased to be working with MedMen as Alternate Health expands into another key state in the U.S. market," said Dr. Michael Murphy, Chairman and CEO of Alternate Health. "The implementation of CanaPass in Canada as well as beta testing in Florida have seen overwhelmingly positive response from our customers and we look forward to serving the medical cannabis community in New York with our state-of-the-art system."
The StatePass system is a cloud-based software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The database is accessible by the patient, certified doctors and licensed dispensaries, linked through a seamless interface, and is used to monitor the individual patient and provide enhanced treatment recommendations, with a focus on improving patient outcomes.
"Alternate Health's agreement with MedMen is perfectly aligned with our goal of bringing best-in-class software solutions to the medical cannabis market," said Jay Briggs, Vice President of Operations of Alternate Health. "This is an exciting opportunity to work side-by-side with another leading company in the cannabis industry and open up new revenue streams in New York's tremendously promising market."
Flow Kana! Humboldt marijuana company.
Meet Flow Kana, similar business model than AHG (they are ahead with their business plan) however very interesting it validates the Four Twenty Inc. business model.
https://www.marketwatch.com/story/the-weed-middleman-that-expects-to-make-billions-as-the-sunkist-of-pot-2019-01-11?fbclid=IwAR3qKJ2Mrs_96AZkaCzseIPc66buMsZ2sUGzoNKJoomkoKysOxHXNdoOK8M
Flow Kana, one of the largest legitimate cannabis distributors in California, has built relationships with more than 100 farmers in the state’s Emerald Triangle — a region consisting of Humboldt, Mendocino and Trinity counties, renowned for their pot-growing prowess — and expected to finish 2018 with revenue of $27.5 million, according to information provided to prospective investors that MarketWatch obtained
The company expects revenue to balloon to $2.26 billion by 2022, and profitability to arrive in 2020.
Flow Kana! Humboldt marijuana company.
Meet Flow Kana, similar business model than AHG (they are ahead with their business plan) however very interesting it validates the Four Twenty Inc. business model.
https://www.marketwatch.com/story/the-weed-middleman-that-expects-to-make-billions-as-the-sunkist-of-pot-2019-01-11?fbclid=IwAR3qKJ2Mrs_96AZkaCzseIPc66buMsZ2sUGzoNKJoomkoKysOxHXNdoOK8M
Flow Kana, one of the largest legitimate cannabis distributors in California, has built relationships with more than 100 farmers in the state’s Emerald Triangle — a region consisting of Humboldt, Mendocino and Trinity counties, renowned for their pot-growing prowess — and expected to finish 2018 with revenue of $27.5 million, according to information provided to prospective investors that MarketWatch obtained
The company expects revenue to balloon to $2.26 billion by 2022, and profitability to arrive in 2020.
$ahg $AHGIF going to have a big 2019. Focus on Cali w
licenses and great tech.
See board for DD https://investorshub.advfn.com/Alternate-Health-Corp-AHGIF-32523/
$ahg $AHGIF going to have a big 2019. Focus on Cali w
licenses and great tech.
See board for DD https://investorshub.advfn.com/Alternate-Health-Corp-AHGIF-32523/
You have no idea what you are talking about :)
Look at recent entry into California Cannabis Space.
$AHG.C / $AHGIF loat float runner .. moves on little volume!
Moves w Little Volume! Great US tech / Cannabis play.
CSE: AHG.C
Up 20% .48 +.08 in Canada
and OTCMKTS: AHGIF
0.36 USD +0.066 (22.85%) in USA
Market Cap: CA$27,050,838
Shares outstanding: 67,627,096. (Mostly insider holdings - they haven't sold one cent).
Licenses in Cali.
Tech partners w/ $MMEN and $LHS.
$AHG.C / $AHGIF Up big on Friday on Little VOLUME!
Moves w Little Volume! Great US tech / Cannabis play.
CSE: AHG.C
Up 20% .48 +.08 in Canada
and OTCMKTS: AHGIF
0.36 USD +0.066 (22.85%) in USA
Market Cap: CA$27,050,838
Shares outstanding: 67,627,096. (Mostly insider holdings - they haven't sold one cent).
Licenses in Cali.
Tech partners w/ $MMEN and $LHS.
Relationship b/w AHG and LHS?
News Release:
Liberty Health Sciences Taps FlorPass As Florida’s First Online Shopping Portal For Its Premium Cannabis Products
(“Liberty” or the “Company”), a provider of trusted, high quality cannabis experiences, announced today that it has received approval by the Florida Department of Health to implement FlorPass as the state’s first online patient management system, connecting patients, physicians and cannabis retailers in one system to provide enhanced care.
FlorPass is developed by Alternate Health Corp
FlorPass is developed by Alternate Health Corp., an international corporation that provides software solutions for the medical cannabis industry. FlorPass is the Florida equivalent of Alternate Health’s CanaPass Cannabis Compliance technology, which is currently operational nationwide in Canada.
- https://www.newcannabisventures.com/liberty-health-sciences-taps-florpass-as-floridas-first-online-shopping-portal-for-its-premium-cannabis-products/
Relationship b/w AHG and MedMen?
News Release:
Alternate Health Signs Agreement with Medmen to Launch Statepass Beta in New York Dispensaries
https://www.prnewswire.com/news-releases/alternate-health-signs-agreement-with-medmen-to-launch-statepass-beta-in-new-york-dispensaries-675529303.html
("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international corporation that provides software solutions for the medical cannabis industry, today announced that the Company has entered into a software-as-a-service agreement with MedMen, one of the largest cannabis companies in the U.S., to provide e-commerce and digital payment services. Alternate Health's StatePass system will begin beta testing with MedMen in their New York dispensaries.
"We are very pleased to be working with MedMen as Alternate Health expands into another key state in the U.S. market," said Dr. Michael Murphy, Chairman and CEO of Alternate Health. "The implementation of CanaPass in Canada as well as beta testing in Florida have seen overwhelmingly positive response from our customers and we look forward to serving the medical cannabis community in New York with our state-of-the-art system."
The StatePass system is a cloud-based software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The database is accessible by the patient, certified doctors and licensed dispensaries, linked through a seamless interface, and is used to monitor the individual patient and provide enhanced treatment recommendations, with a focus on improving patient outcomes.
"Alternate Health's agreement with MedMen is perfectly aligned with our goal of bringing best-in-class software solutions to the medical cannabis market," said Jay Briggs, Vice President of Operations of Alternate Health. "This is an exciting opportunity to work side-by-side with another leading company in the cannabis industry and open up new revenue streams in New York's tremendously promising market."
NAC involved heavily w latest AHG Private placement round.
3 major participants in the last private placement round for $AHG all have direct connections to NAC. Alternative health has also participated in previous NAC PP rounds.
Here is what I have learned.
1) PI Financial Corp. ITF Paskwayak Business Development Corporation Ltd. Opaskwyak, Manitoba Bought 3.75 Million shares in the last Private Placement.
After doing some digging i noticed that Paskwayak Business Development Corporation are First Nations from the Opaskwayak Cree Nation.
- They are heavily invested in National Access Cannabis Corp.
https://ceo.ca/@nasdaq/paskwayak-business-development-corporation-acquires
- They are also invested in Trichome Financial Corp. (Specialty Finance for the Cannabis Industry)
https://www.newswire.ca/news-releases/trichome-financial-corp-announces-closing-of-private-placement-and-provides-corporate-update-692684761.html
2) PI Financial Corp.For: Mark Goliger Burlington, ON bought 125,000 shares. He is CEO of National Access Cannabis.
3) Rocco Meliambro has 750,000 shares. He is on the board of National Access Cannabis Corp
See full list of AHG Private placement participants here: https://webfiles.thecse.com/CSE_Form_9_-_NoticeofIssuanceofSecurities_-_21Dec18_-_final.pdf
Read more at http://www.stockhouse.com/companies/bullboard#qJypKkrAe8iHP0Ib.99
NAC involved heavily w latest $AHG Private placement round.
3 major participants in the last private placement round for $AHG all have direct connections to NAC. Alternative health has also participated in previous NAC PP rounds.
Here is what I have learned.
1) PI Financial Corp. ITF Paskwayak Business Development Corporation Ltd. Opaskwyak, Manitoba Bought 3.75 Million shares in the last Private Placement.
After doing some digging i noticed that Paskwayak Business Development Corporation are First Nations from the Opaskwayak Cree Nation.
- They are heavily invested in National Access Cannabis Corp.
https://ceo.ca/@nasdaq/paskwayak-business-development-corporation-acquires
- They are also invested in Trichome Financial Corp. (Specialty Finance for the Cannabis Industry)
https://www.newswire.ca/news-releases/trichome-financial-corp-announces-closing-of-private-placement-and-provides-corporate-update-692684761.html
2) PI Financial Corp.For: Mark Goliger Burlington, ON bought 125,000 shares. He is CEO of National Access Cannabis.
3) Rocco Meliambro has 750,000 shares. He is on the board of National Access Cannabis Corp
See full list of AHG Private placement participants here: https://webfiles.thecse.com/CSE_Form_9_-_NoticeofIssuanceofSecurities_-_21Dec18_-_final.pdf
Let's take a look at at LHS’s ecommerce / tech partner $AHG Alternate Health.
I figured all of the LHS shareholders would want to know some more about their tech / ecommerce partner.
Ticker $AHG $AHGIF
- Currently trading at the last PP round it did this month (a lot of strategic investors participated in this round).
- SP is $0 .40
- Current MP 27.02M
- Shares outstanding: 53m
- Recent acquisition of manufacturing, and distribution licenses in Humboldt County, CA
- Stong tech / ecommerce relationship w Liberty Health Sciences, and MedMen
- For full DD on Alternate Health $AHG visit their SH board (a few GEM POSTS) ... or join the FB group https://www.facebook.com/groups/AHGInvestorsGroup/
Relationship b/w AHG and LHS?
News Release:
Liberty Health Sciences Taps FlorPass As Florida’s First Online Shopping Portal For Its Premium Cannabis Products
(“Liberty” or the “Company”), a provider of trusted, high quality cannabis experiences, announced today that it has received approval by the Florida Department of Health to implement FlorPass as the state’s first online patient management system, connecting patients, physicians and cannabis retailers in one system to provide enhanced care.
FlorPass is developed by Alternate Health Corp
FlorPass is developed by Alternate Health Corp., an international corporation that provides software solutions for the medical cannabis industry. FlorPass is the Florida equivalent of Alternate Health’s CanaPass Cannabis Compliance technology, which is currently operational nationwide in Canada.
- https://www.newcannabisventures.com/liberty-health-sciences-taps-florpass-as-floridas-first-online-shopping-portal-for-its-premium-cannabis-products/
Let's take a look at MedMen’s ecommerce / tech partner $AHG Alternate Health.
I figured all of the MMEN shareholders would want to know some more about their tech / ecommerce partner.
Ticker $AHG $AHGIF
- Currently trading at the last PP round it did this month.
- SP is $0 .40
- Current MP 27.02M
- Shares outstanding: 53m
- Recent acquisition of manufacturing, and distribution licenses in Humboldt County, CA
- Stong tech / ecommerce relationship w Liberty Health Sciences, and MedMen
- For full DD on Alternate Health $AHG visit their SH board or join the FB group https://www.facebook.com/groups/AHGInvestorsGroup/
Relationship b/w AHG and MedMen?
News Release:
Alternate Health Signs Agreement with Medmen to Launch Statepass Beta in New York Dispensaries
https://www.prnewswire.com/news-releases/alternate-health-signs-agreement-with-medmen-to-launch-statepass-beta-in-new-york-dispensaries-675529303.html
("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international corporation that provides software solutions for the medical cannabis industry, today announced that the Company has entered into a software-as-a-service agreement with MedMen, one of the largest cannabis companies in the U.S., to provide e-commerce and digital payment services. Alternate Health's StatePass system will begin beta testing with MedMen in their New York dispensaries.
"We are very pleased to be working with MedMen as Alternate Health expands into another key state in the U.S. market," said Dr. Michael Murphy, Chairman and CEO of Alternate Health. "The implementation of CanaPass in Canada as well as beta testing in Florida have seen overwhelmingly positive response from our customers and we look forward to serving the medical cannabis community in New York with our state-of-the-art system."
The StatePass system is a cloud-based software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The database is accessible by the patient, certified doctors and licensed dispensaries, linked through a seamless interface, and is used to monitor the individual patient and provide enhanced treatment recommendations, with a focus on improving patient outcomes.
"Alternate Health's agreement with MedMen is perfectly aligned with our goal of bringing best-in-class software solutions to the medical cannabis market," said Jay Briggs, Vice President of Operations of Alternate Health. "This is an exciting opportunity to work side-by-side with another leading company in the cannabis industry and open up new revenue streams in New York's tremendously promising market."
AHG.C / AHGIF Up big on Friday on Little VOLUME!
Moves w Little Volume! Great US tech / Cannabis play.
CSE: AHG.C
Up 20% .48 +.08 in Canada
and OTCMKTS: AHGIF
0.36 USD +0.066 (22.85%) in USA
Market Cap: CA$27,050,838
Shares outstanding: 67,627,096. (Mostly insider holdings - they haven't sold one cent).
Licenses in Cali.
Tech partners w/ $MMEN and $LHS.
AHG.C / AHGIF Up big Friday on Little VOLUME!
Moves w Little Volume! Great US tech / Cannabis play.
CSE: AHG.C
Up 20% .48 +.08 in Canada
and OTCMKTS: AHGIF
0.36 USD +0.066 (22.85%) in USA
Market Cap: CA$27,050,838
Shares outstanding: 67,627,096. (Mostly insider holdings - they haven't sold one cent).
Licenses in Cali.
Tech partners w/ $MMEN and $LHS.
Up big Friday on Little VOLUME!
CSE: AHG.C
Up 20% .48 +.08 in Canada
and OTCMKTS: AHGIF
0.36 USD +0.066 (22.85%) in USA
VIDEO: Canada House Wellness is a Fully Integrated Company that Validates Medical Patients
https://www.midasletter.com/2018/02/video-canada-house-wellness-fully-integrated-company-validates-medical-patients/
(SARSF) is UnderValued and gonna be $2-$3 with sales license. Canadian Ticker (CHV)
FB investors Group: https://www.facebook.com/groups/chvinvestorsgroup/
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
FB investors Group Link:
https://www.facebook.com/groups/chvinvestorsgroup/
Feel free to join!
Go CHV! :)
(NXTTF) (N) Namaste will get their Sales License sometime in Feb. and SP will be well above $3 if there is a Bull market. Days like today are Buying days (Dips). At 1.80 it's a STEAL!
(NXTTF) (N) Namaste will get their Sales License sometime in Feb. and SP will be well above $3 if there is a Bull market. Days like today are Buying days (Dips). At 1.80 it's a STEAL!
Namaste will get their Sales License sometime in Feb. and SP will be well above $3 if there is a Bull market. Days like today are Buying days (Dips). Stay Strong!
Canada House Wellness – The Undervalued Cannabis Player
(CHV) or (SARSF) is UnderValued and is gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(CHV) or (SARSF) is UnderValued and is gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(CHV) or (SARSF) is UnderValued and is gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(CHV) or (SARSF) is UnderValued and is gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
Amazing thanks for joining the party. (CHV) or (SARSF) is UnderValued and gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(SARSF) or (CHV) Jumping and has volume. Cultivation license already with sales license on the way! Canada House Wellness Group Inc!
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(SARSF) or (CHV) Jumping and has volume. Cultivation license already with sales license on the way! Canada House Wellness Group Inc!
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
(SARSF) or (CHV) Is way Undervalued. Cultivation license already with sales license on the way! Canada House Wellness Group Inc!
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
$SARSF or $CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
$SARSF or $CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
Yes i love PAOG Great message..
Everyone should be spreading the word :)